Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo

Immunity

Volumn 10, Issue 4, 1999, Pages 431-438

  Poignard, Pascal ^a   Sabbe, Rebecca ^a   Picchio, Gaston R ^a   Wang, Meng ^a   Gulizia, Richard J ^a   Katinger, Hermann ^b   Parren, Paul W H I ^a   Mosier, Donald E ^a   Burton, Dennis R ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIBODY TITER; ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SCID MOUSE; VIRUS LOAD; VIRUS NEUTRALIZATION; VIRUS REPLICATION;

EID: 0033119374     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80043-6     Document Type: Article

References (35)

1. Albert, J., Abrahamsson, B., Nagy, K., Aurelius, E., Gaines, H., Nystrom, G., and Fenyo, E.M. (1990). Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera. AIDS 4, 107-112.
2. Andrus, L., Prince, A.M., Bernal, I., McCormack, P., Lee, D.H., Gorny, M.K., and Zolla-Pazner, S. (1998). Passive immunization with a human immunodeficiency virus type 1-neutralizing monoclonal antibody in Hu-PBL-SCID mice: Isolation of a neutralization escape variant. J. Infect. Dis. 177, 889-897.
3. Arendrup, M., Nielsen, C., Hansen, J.E., Pedersen, C., Mathiesen, L., and Nielsen, J.O. (1992). Autologous HIV-1 neutralizing antibodies: Emergence of neutralization-resistant escape virus and subsequent development of escape virus neutralizing antibodies. J. Acquir. Immune Defic. Syndr. 5, 303-307.
4. Burton, D.R., and Montefiori, D. (1997). The antibody response in HIV-1 infection. AIDS 11 Suppl A, S87-S98.
5. Burton, D.R., Barbas, C.F. III, Persson, M., Koenig, S., Chanock, R., and Lerner, R. (1991). A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. Proc. Natl. Acad. Sci. USA 88, 10134-10137.
6. Burton, D.R., Pyati, J., Koduri, R., Sharp, S.J., Thornton, G.B., Parren, P.W.H.I., Sawyer, L.S., Hendry, R.M., Dunlop, N., Nara, P.L., et al. (1994). Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science 266, 1024-1027.
7. Cheng-Mayer, C., and Levy, J.A. (1988). Distinct biological and serological properties of human immunodeficiency viruses from the brain. Ann. Neurol. 23, S58-S61.
8. Coffin, J.M. (1995). HIV population dynamics in vivo: Implications for genetic variation, pathogenesis, and therapy. Science 267, 483-489.
9. D'Souza, M.P., Livnat, D., Bradac, J.A., and Bridges, S.H. (1997). Evaluation of monoclonal antibodies to human immunodeficiency virus type 1 primary isolates by neutralization assays: Performance criteria for selecting candidate antibodies for clinical trials. AIDS clinical trials group antibody selection working group. J. Infect. Dis. 175, 1056-1062.
10. Gauduin, M.C., Safrit, J.T., Weir, R., Fung, M.S., and Koup, R.A. (1995). Pre- and postexposure protection against human immunodeficiency virus type 1 infection mediated by a monoclonal antibody. J. Infect. Dis. 171, 1203-1209.
11. Gauduin, M.C., Parren, P.W.H.I., Weir, R., Barbas, C.F., Burton, D.R., and Koup, R.A. (1997). Passive immunization with a human monoclonal antibody protects Hu-PBL-SCID mice against challenge by primary isolates of HIV-1. Nat. Med. 3, 1389-1393.
12. Gunthard, H.F., Wong, J.K., Ignacio, C.C., Guatelli, J.C., Riggs, N.L., Havlir, D.V., and Richman, D.D. (1998). Human immunodeficiency virus replication and genotypic resistance in blood and lymph nodes after a year of potent antiretroviral therapy. J. Virol. 72, 2422-2428.
13. Ho, D.D., Neumann, A.U., Perelson, A.S., Chen, W., Leonard, J.M., and Markowitz, M. (1995). Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123-126.
14. Koyanagi, Y., Miles, S., Mitsuyasu, R., Merrill, J., Vinters, H., and Chen, I. (1987). Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 236, 819-822.
15. Mo, H., Stamatatos, L., Ip, J.E., Barbas, C.F., Parren, P.W.H.I., Burton, D.R., Moore, J.P., and Ho, D.D. (1997). Human immunodeficiency virus type 1 mutants that escape neutralization by human monoclonal antibody igG1b12. J. Virol. 71, 6869-6874.
16. Moore, J.P., and Ho, D.D. (1995). HIV-1 neutralization: The consequences of viral adaptation to growth on transformed T cells. AIDS 9, S117-S136.
17. Moore, J.P., McKeating, J., Weiss, R., and Sattentau, Q.J. (1990). Dissociation of gp120 from HIV-1 virions induced by soluble CD4. Science 250, 1139-1142.
18. Mosier, D.E., Gulizia, R., Baird, S., Wilson, D., Spector, D., and SpecTor, S. (1991). Human immunodeficiency virus infection of human-PBL-SCID mice. Science 251, 791-794.
19. Mosier, D.E., Gulizia, R.J., Macisaac, P.D., Torbett, B.E., and Levy, J.A. (1993). Rapid loss of CD4+ T cells in human-PBL-SCID mice by noncytopathic HIV isolates. Science 260, 689-692.
20. Muster, T., Steindl, F., Purtscher, M., Trkola, A., Klima, A., Himmler, G., Ruker, F., and Katinger, H. (1993). A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. J. Virol. 67, 6642-6647.
21. Pantaleo, G., Demarest, J.F., Vaccarezza, M., Graziosi, C., Bansal, G.P., Koenig, S., and Fauci, A.S. (1995). Effect of anti-V3 antibodies on cell-free and cell-to-cell human immunodeficiency virus transmission. Eur. J. Immunol. 25, 226-231.
22. Parren, P.W.H.I., Ditzel, H.J., Gulizia, R.J., Binley, J.M., Barbas, C.F. III, Burton, D.R., and Mosier, D.E. (1995). Protection against HIV-1 infection in Hu-PBL-SCID mice by passive immunization with a neutralizing human monoclonal antibody against the gp120 CD4-binding site. AIDS 9, F1-F6.
23. Parren, P.W.H.I., Mondor, I., Naniche, D., Ditzel, H.J., Klasse, P.J., Burton, D.R., and Sattentau, Q.J. (1998a). Neutralization of human immunodeficiency virus type 1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificity. J. Virol. 72, 3512-3519.
24. Parren, P.W.H.I., Wang, M., Trkola, A., Binley, J.M., Purtscher, M., Katinger, H., Moore, J.P., and Burton, D.R. (1998b). Antibody neutralization-resistant primary isolates of human immunodefiency virus type 1. J. Virol. 72, 10270-10274.
25. Perelson, A.S., Neumann, A.U., Markowitz, M., Leonard, J.M., and Ho, D.D. (1996). HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time. Science 271, 1582-1586.
26. Pettoello-Mantovani, M., Kollmann, T.R., Katopodis, N.F., Raker, C., Kim, A., Yurasov, S., Wiltshire, H., and Goldstein, H. (1998). Thy/ liv-scid-hu mice: A system for investigating the in vivo effects of multidrug therapy on plasma viremia and human immunodeficiency virus replication in lymphoid tissues. J. Infect. Dis. 177, 337-346.
27. Pilgrim, A.K., Pantaleo, G., Cohen, O.J., Fink, L.M., Zhou, J.Y., Zhou, J.T., Bolognesi, D.P., Fauci, A.S., and Montefiori, D.C. (1997). Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection. J. Infect. Dis. 176, 924-932.
28. Pulito, V., Roberts, V., Adair, J., Rothermel, A., Collins, A., Varga, S., Martocello, C., Bodmer, M., Jolliffe, L., and Zivin, R. (1996). Humanization and molecular modeling of the anti-CD4 monoclonal antibody, OKT4A. J. Immunol. 156, 2840-2850.
29. Roben, P., Moore, J.P., Thali, M., Sodroski, J., Barbas, C.F. III, and Burton, D.R. (1994). Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1. J. Virol. 68, 4821-4828.
30. Safrit, J.T., Fung, M.S., Andrews, C.A., Braun, D.G., Sun, W.N., Chang, T.W., and Koup, R.A. (1993). Hu-PBL-SCID mice can be protected from HIV-1 infection by passive transfer of monoclonal antibody to the principal neutralizing determinant of envelope gp120. AIDS 7, 15-21.
31. Sattentau, Q.J., and Moore, J.P. (1995). Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer. J. Exp. Med. 182, 185-196.
32. Schønning, K., Joost, M., Gram, G.J., Machuca, R., Nielsen, C., Nielsen, J.O., and Hansen, J.E. (1998). Chemokine receptor polymorphism and autologous neutralizing antibody response in long-term HIV-1 infection. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 18, 195-202.
33. Tremblay, M., and Wainberg, M.A. (1990). Neutralization of multiple HIV-1 isolates from a single subject by autologous sequential sera. J. Infect. Dis. 162, 735-737.
34. Trkola, A., Purtscher, M., Muster, T., Ballaun, C., Buchacher, A., Sullivan, N., Srinivasan, K., Sodroski, J., Moore, J.P., and Katinger, H. (1996). Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J. Virol. 70, 1100-1108.
35. Van Rompay, K.K., Berardi, C.J., Dillard-Telm, S., Tarara, R.P., Canfield, D.R., Valverde, C.R., Montefiori, D.C., Cole, K.S., Montelaro, R.C., Miller, C.J., et al. (1998). Passive immunization of newborn rhesus macaques prevents oral simian immunodeficiency virus infection. J. Infect. Dis. 177, 1247-1259.